AstraZeneca admits for first time its Covid vaccine can cause rare side effect The Telegraph - 28 Apr 2024 AstraZeneca admits for first time its Covid vaccine can cause rare side effect ... More
AstraZeneca CEO on US-China tensions: 'We have established a very resilient supply chain' Yahoo Finance - 25 Apr 2024 AstraZeneca CEO on US-China tensions: 'We have established a very resilient supply chain' ... More
AstraZeneca Admits Its Vaxxes Cause Clots Newsmax - 28 Apr 2024 AstraZeneca Admits Its Vaxxes Cause Clots ... More
AstraZeneca leaps after smashing first-quarter forecasts Reuters - 25 Apr 2024 AstraZeneca leaps after smashing first-quarter forecasts ... More
The danger in saying yes to Pascal Soriot’s pay rise at AstraZeneca The Guardian - 11 Apr 2024 The danger in saying yes to Pascal Soriot’s pay rise at AstraZeneca ... More
AstraZeneca shareholders approve CEO Soriot's £18.7mn pay despite revolt Financial Times - 11 Apr 2024 AstraZeneca shareholders approve CEO Soriot's £18.7mn pay despite revolt ... More
AstraZeneca CEO’s £18.7m pay approved despite shareholder rebellion The Guardian - 11 Apr 2024 AstraZeneca CEO’s £18.7m pay approved despite shareholder rebellion ... More
AstraZeneca's Pascal Soriot 'massively underpaid' at £16.9mn, says top shareholder Financial Times - 09 Apr 2024 AstraZeneca's Pascal Soriot 'massively underpaid' at £16.9mn, says top shareholder ... More
AstraZeneca shareholders urged to oppose pay plan for CEO Soriot Financial Times - 30 Mar 2024 AstraZeneca shareholders urged to oppose pay plan for CEO Soriot ... More
AstraZeneca Plc (AZN) Q1 2024 Earnings Call Transcript The Motley Fool - 25 Apr 2024 AstraZeneca Plc (AZN) Q1 2024 Earnings Call Transcript ... More
Sanofi and AstraZeneca Scrap Several Early-Stage Programs in Q1 BioSpace - 25 Apr 2024 Sanofi and AstraZeneca Scrap Several Early-Stage Programs in Q1 ... More
AstraZeneca Gets a Boost From Sales of Its Cancer Drugs Investopedia - 25 Apr 2024 AstraZeneca Gets a Boost From Sales of Its Cancer Drugs ... More
AstraZeneca and Merck's Lynparza set to 'dominate' PARP market as it looks to grow cancer offerings with 100-plus ... FiercePharma - 24 Apr 2024 AstraZeneca and Merck's Lynparza set to 'dominate' PARP market as it looks to grow cancer offerings with 100-plus ... ... More
AstraZeneca Stock Flirts With Breakout As Cancer Drug Sales Shine; Sanofi, Bristol Stocks Diverge Investor's Business Daily - 25 Apr 2024 AstraZeneca Stock Flirts With Breakout As Cancer Drug Sales Shine; Sanofi, Bristol Stocks Diverge ... More
AstraZeneca encounters a surge in shares as profits exceed expectations, buoyed by demand for cancer drugs Fortune - 25 Apr 2024 AstraZeneca encounters a surge in shares as profits exceed expectations, buoyed by demand for cancer drugs ... More
AstraZeneca’s Profit Gains on Sales of Cancer Drugs Bloomberg - 25 Apr 2024 AstraZeneca’s Profit Gains on Sales of Cancer Drugs ... More
AstraZeneca Posts Bumper Earnings On Strong Sales From Cancer Drugs, Sticks To Annual Guidance Yahoo Finance - 25 Apr 2024 AstraZeneca Posts Bumper Earnings On Strong Sales From Cancer Drugs, Sticks To Annual Guidance ... More
AstraZeneca posts $2.18bn profit after tax in Q1 2024 Pharmaceutical Technology - 26 Apr 2024 AstraZeneca posts $2.18bn profit after tax in Q1 2024 ... More
AstraZeneca drops GOLDILOX and the porcupine in R&D update Fierce Biotech - 25 Apr 2024 AstraZeneca drops GOLDILOX and the porcupine in R&D update ... More